Medical News

RSS

Access receives first MuGard prescriptions and reimbursement

Access Pharmaceuticals, Inc., a biopharmaceutical company specializing in products for cancer and supportive care, announced today it has received initial prescriptions for its lead product, MuGard – an FDA-approved, ready-to-use mucoadhesive oral wound rinse for the management of oral mucositis, a debilitating side effect of radiotherapy and/or chemotherapy.

15 Oct 2010

WSNA sues 4 hospitals for failing to provide nurses with rest and meal breaks

Washington State Nurses Association (WSNA), representing more than 16,000 registered nurses in Washington State, has filed lawsuits against four hospitals around the state for failing to provide nurses with rest and meal breaks. Research confirms that nurses working long hours have decreased alertness and vigilance which can lead to an increase in medical errors and compromised patient care. WSNA has been working for several years to ensure that nurses receive full, uninterrupted breaks because that dedicated time to rest is critical in preventing fatigue and fatigue-related errors.

15 Oct 2010

Canon to preview CR-2 Digital Non-Mydriatic Retinal Camera at AAO Annual Meeting

Canon U.S.A., Inc., a leader in digital imaging, will preview the lightest Canon retinal camera to-date, the CR-2 Digital Non-Mydriatic Retinal Camera, at the American Academy of Ophthalmology's (AAO) Annual Meeting (October 16 - 19). In addition to the CR-2 retinal camera, which is awaiting FDA clearance, visitors will be able to explore the Company's current full line of ophthalmic solutions in the Canon booth (booth #: 2208).

15 Oct 2010

Oseltamivir reduces mortality in influenza A/H5N1 patients

A study published in the Journal of Infectious Diseases indicates that treatment with oseltamivir significantly reduces mortality in patients with influenza A/H5N1, or 'bird flu', even when given late in the course of illness.

15 Oct 2010

MDS Nordion named one of Canada's Top 100 Employers

For the second straight year, MDS Nordion, a leading provider of products and services to the global health science market, has been named one of Canada's Top 100 Employers by Mediacorp Canada, the nation's largest publisher of employment-related periodicals and online directories.

15 Oct 2010

Crosstex International introduces customized surgical masks

Cantel Medical Corp., announced today the launch of a new, unique design of medical face masks - the SecureFit™ series by Crosstex International, a Cantel subsidiary and a leading U.S. manufacturer of medical face masks. The SecureFit™ series of masks addresses scientific research that points to poorly fitting masks as a major hindrance to their effectiveness.

15 Oct 2010

Medtronic CoreValve System IDE for transcatheter aortic valve implantation receives FDA approval

Medtronic, Inc. today announced U.S. Food and Drug Administration (FDA) conditional approval for its Investigational Device Exemption (IDE) application and pivotal clinical trial protocol to begin evaluating the Medtronic CoreValve System for transcatheter aortic valve implantation (TAVI).

15 Oct 2010

Enrollment complete in Inhibitex's FV-100 Phase II clinical trial in shingles patients

Inhibitex, Inc., announced today that it has completed enrollment in a Phase II clinical trial of FV-100 in shingles (herpes zoster) patients. The objectives of the trial are to further evaluate the safety of FV-100 and its potential therapeutic benefit in reducing the severity and duration of shingles-associated pain, the incidence of post herpetic neuralgia (PHN), and the time to heal shingles-related lesions.

15 Oct 2010

Essilor International to acquire 50% of Shamir Optical

Shamir Optical Industry Ltd. Kibbutz Shamir and Essilor International today announced that they have signed an agreement whereby Essilor will, through a series of transactions, acquire 50% of Shamir Optical. As a result of these transactions, Kibbutz Shamir and Essilor will each own 50% of Shamir Optical.

15 Oct 2010

Watson Laboratories receives FDA approval for Amlodipine capsules

Watson Pharmaceuticals, Inc. today announced that its subsidiary, Watson Laboratories, Inc., has received approval from the United States Food and Drug Administration on its Abbreviated New Drug Application (ANDA) for Amlodipine Besylate/Benazepril 5/20mg, 10/20mg, 2.5/10mg, and 5/10mg capsules, the generic equivalent to Novartis' Lotrel capsules.

15 Oct 2010

Pericytes regulate blood-brain barrier

While the blood-brain barrier (BBB) protects the brain from harmful chemicals occurring naturally in the blood, it also obstructs the transport of drugs to the brain. In an article in Nature scientists at the Swedish medical university Karolinska Institutet now present a potential solution to the problem. The key to the BBB is a cell-type in the blood vessel walls called pericytes, and the researchers hope that their findings will one day contribute to new therapies for diseases like Alzheimer's and stroke.

15 Oct 2010

NovaBay to present two poster presentations at IDSA Annual Meeting

NovaBay Pharmaceuticals, Inc. a clinical stage biotechnology company developing first-in-class, anti-infective compounds for the treatment and prevention of antibiotic-resistant infections, announces that it will deliver two poster presentations on its compounds at the 48th Annual Meeting of the Infectious Diseases Society of America (IDSA).

15 Oct 2010

Allegheny expects $0.26 net income for third quarter 2010

Allegheny Technologies Incorporated today provided guidance for the third quarter 2010. ATI expects net income per share for the third quarter 2010 before certain charges to be approximately $0.26.

15 Oct 2010

Bristol-Myers, Otsuka launch My SPRYCEL Support program to assist patients with CML

Bristol-Myers Squibb Company and Otsuka Pharmaceutical Co., Ltd. today announced the launch of My SPRYCEL (dasatinib) Support, a useful resource to assist adult patients with chronic myeloid leukemia (CML) who are taking SPRYCEL.

15 Oct 2010

New comprehensive program for medical electronic device designers

Canon Communications today announced the formation of a comprehensive program to assist designers, developers, and engineering managers involved in the design of electronics-based medical devices. The DesignMED conference and exposition is a collaborative project between the company's Medical Device Group-Medical Electronics Design (MED), EDN, and MD+DI-and its Event Division.

15 Oct 2010

CVS Caremark to present client experiences on innovative approaches at AMCP Conference

CVS Caremark is presenting data at the Academy of Managed Care Pharmacy (AMCP) 2010 Educational Conference illustrating how innovative approaches to traditional plan designs can help clients reduce drug spend, improve generic dispensing rates (GDR) and minimize member disruption.

15 Oct 2010

AstraZeneca launches new campaign on depression through Facebook and Twitter

AstraZeneca is launching a new campaign called "Take on Depression" through a "Take on Depression" Facebook page and a @FaceDepression Twitter feed to support, educate, and inspire those affected by bipolar depression and major depressive disorder (MDD), also known as depression.

15 Oct 2010

NASA software could help interpret medical imagery

NASA software used to enhance Earth science imagery could help interpret medical imagery. The new MED-SEG system, developed by Bartron Medical Imaging Inc. of Largo, Md., relies on an innovative software program developed at NASA to help doctors analyze mammograms, ultrasounds, digital X-rays and other medical imaging tests.

15 Oct 2010

NIH awards $1.2M for study on discharge decisions at hospitals

A Georgia State University professor and an Emory University surgeon have received a $1.2 million grant from the National Institutes of Health for a joint research project to study discharge decisions at hospitals.

15 Oct 2010

Acorda presents new analysis of AMPYRA tablets at ECTRIMS Congress

Acorda Therapeutics, Inc. today announced that a new analysis of AMPYRA (dalfampridine) Extended Release Tablets, 10 mg data examining walking improvement in treatment responders has been presented at the 26th Congress of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS).

15 Oct 2010